Evidence map›Paper›PMID 33120990›Full record

ArticleMaterials (Basel, Switzerland)2020

Third-Generation Cephalosporin-Loaded Chitosan Used to Limit Microorganisms Resistance.

Letiția Doina Duceac, Gabriela Calin, Lucian Eva, Constantin Marcu, Elena Roxana Bogdan Goroftei, Marius Gabriel Dabija, Geta Mitrea, Alina Costina Luca, Elena Hanganu, Cristian Gutu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Obtaining and Characterization of New Materials.Materials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Letiția Doina DuceacFaculty of Dental Medicine, "Apollonia" University of Iasi, 11 Pacurari Str., 700511 Iasi, Romania.
Gabriela CalinFaculty of Dental Medicine, "Apollonia" University of Iasi, 11 Pacurari Str., 700511 Iasi, Romania.ORCID 0000-0002-1893-5109
Lucian EvaFaculty of Dental Medicine, "Apollonia" University of Iasi, 11 Pacurari Str., 700511 Iasi, Romania.
Constantin MarcuFaculty of Medicine and Pharmacy, University Dunarea de Jos, 47 Domneasca Str., 800008 Galati, Romania getamitrea@yahoo.com (G.M.).
Elena Roxana Bogdan GorofteiFaculty of Medicine and Pharmacy, University Dunarea de Jos, 47 Domneasca Str., 800008 Galati, Romania getamitrea@yahoo.com (G.M.).
Marius Gabriel DabijaNicolae Oblu Neurosurgery Hospital of Iasi, 2 Ateneului, 700309 Iasi, Romania.
Geta MitreaFaculty of Medicine and Pharmacy, University Dunarea de Jos, 47 Domneasca Str., 800008 Galati, Romania getamitrea@yahoo.com (G.M.).
Alina Costina Luca"Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 16 Universitatii Str., 700115 Iasi, Romania.
Elena Hanganu"Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 16 Universitatii Str., 700115 Iasi, Romania.
Cristian GutuFaculty of Medicine and Pharmacy, University Dunarea de Jos, 47 Domneasca Str., 800008 Galati, Romania getamitrea@yahoo.com (G.M.).
Liviu StafieFaculty of Dental Medicine, "Apollonia" University of Iasi, 11 Pacurari Str., 700511 Iasi, Romania.
Elena Ariela BanuFaculty of Medicine and Pharmacy, University Dunarea de Jos, 47 Domneasca Str., 800008 Galati, Romania getamitrea@yahoo.com (G.M.).
Carmen GrierosuFaculty of Dental Medicine, "Apollonia" University of Iasi, 11 Pacurari Str., 700511 Iasi, Romania.
Alin Constantin IordacheNicolae Oblu Neurosurgery Hospital of Iasi, 2 Ateneului, 700309 Iasi, Romania.
Apollonia University · RO"Dunarea de Jos" University of Galati · ROGrigore T. Popa University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From their discovery, antibiotics have significantly improved clinical treatments of infections, thus leading to diminishing morbidity and mortality in critical care patients, as well as surgical, transplant and other types of medical procedures. In contemporary medicine, a significant debate regarding the development of multi-drug resistance involves all types of pathogens, especially in acute care hospitals due to suboptimal or inappropriate therapy. The possibility of nanotechnology using nanoparticles as matrices to encapsulate a lot of active molecules should increase drug efficacy, limit adverse effects and be an alternative helping to combat antibiotic resistance. The major aim of this study was to obtain and to analyze physico-chemical features of chitosan used as a drug-delivery system in order to stop the antibiotic resistance of different pathogens. It is well known that World Health Organization stated that multidrug resistance is one of the most important health threats worldwide. In last few years, nano-medicine emerged as an improved therapy to combat antibiotic-resistant infections agents. This work relies on enhancement of the antimicrobial efficiency of ceftriaxone against gram(+) and gram(-) bacteria by antibiotic encapsulation into chitosan nanoparticles. Physicochemical features of ceftriaxone-loaded polymer nanoparticles were investigated by particle size distribution and zeta potential, Fourier-transform infrared spectroscopy (FTIR), Thermal Gravimetric Analysis (TG/TGA), Scanning Electron Microscopy (SEM) characteristics techniques. The obtained results revealed an average particle size of 250 nm and a zeta potential value of 38.5 mV. The release profile indicates an incipient drug deliverance of almost 15%, after 2 h of approximately 83%, followed by a slowed drug release up to 24 h. Characteristics peaks of chitosan were confirmed by FTIR spectra indicating a similar structure in the case of ceftriaxone-loaded chitosan nanoparticles. A good encapsulation of the antibiotic into chitosan nanoparticles was also provided by thermo-gravimetric analysis. Morphological characteristics shown by SEM micrographs exhibit spherical nanoparticles of 30-250 nm in size with agglomerated architectures. Chitosan, a natural polymer which is used to load different drugs, provides sustained and prolonged release of antibiotics at a specific target by possessing antimicrobial activity against gram(+) and gram(-) bacteria. In this research, ceftriaxone-loaded chitosan nanoparticles were investigated as a carrier in antibiotic delivery.

Indexed as

cardiologychitosanepidemiologyneurosurgeryobstetrics/gynecologyorthopedicspediatricspediatric surgerypulmonology

Identifiers

PMID33120990
PMCPMC7662494
OpenAlexW3096286023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.